pramipexole has been researched along with thiazolyl blue in 2 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (thiazolyl blue) | Trials (thiazolyl blue) | Recent Studies (post-2010) (thiazolyl blue) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 4,625 | 20 | 1,230 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borwege, S; Hagner, D; Joyce, JN; Millan, MJ; Osredkar, T; PazSoldan, M; Presgraves, S; Renish, L; Replogle, M | 1 |
| Ei-Fakhrany, A; Isosaki, M; Kyotani, Y; Nakayama, H; Satoh, H; Yoshizumi, M; Zhao, J | 1 |
2 other study(ies) available for pramipexole and thiazolyl blue
| Article | Year |
|---|---|
Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Benzothiazoles; Cell Count; Cell Line; DNA; Dopamine Agents; Dopamine Agonists; Humans; Immunohistochemistry; Indoles; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxazines; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrazolium Salts; Thiazoles | 2003 |
Neuroprotective effects of pramipexole against tunicamycin-induced cell death in PC12 cells.
Topics: Animals; Apoptosis; Benzothiazoles; Cell Death; Dopamine Agonists; Dopamine Antagonists; Endoplasmic Reticulum; L-Lactate Dehydrogenase; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Pramipexole; Rats; Spiperone; Tetrazolium Salts; Thiazoles; Tunicamycin | 2009 |